Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
09/2005
09/13/2005CA2279276C Arylsulfonylamino hydroxamic acid derivatives
09/09/2005WO2005083124A1 Antisense oligonucleotide modulation of stat3 expression
09/09/2005WO2005083071A1 Polynucleotide participating in rheumatoid arthritis and utilization of the same
09/09/2005WO2005082905A1 Bicyclic heterocyclic compound
09/09/2005WO2005082904A1 Preventive and/or therapeutic agent for neutrophilic inflammation disease
09/09/2005WO2005082887A1 Pyrimidine derivative
09/09/2005WO2005082872A1 Benzothiazin-3-one compound and intermediate therefor
09/09/2005WO2005082865A1 Fused bicyclic pyrimidine derivative
09/09/2005WO2005082847A1 Bicyclo derivative
09/09/2005WO2005082369A1 Opioid delivery system
09/09/2005WO2005082079A2 Tetracyclic lactam derivatives and uses thereof
09/09/2005WO2005014584A8 3-(indol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones,3-(benzimidazol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones, and 3-(indolin-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones; their preparation and use as modulators of apoptosis
09/09/2005WO2004111090A3 Molecules for targeting and releasing therapeutic compounds, and the use thereof
09/09/2005WO2003057854A3 Novel proteins and nucleic acids encoding same
09/09/2005CA2599022A1 Opioid delivery system
09/09/2005CA2560664A1 Benzothiazin-3-one compound and intermediate therefor
09/09/2005CA2557541A1 Pyrimidine derivatives
09/09/2005CA2557444A1 Furosemide derivatives as modulators of hm74 and their use for the treatment of inflammation
09/09/2005CA2557278A1 Glucocorticoid receptor modulator compounds and methods- utility
09/09/2005CA2557276A1 Preventive and/or therapeutic agent for neutrophilic inflammatory diseases
09/09/2005CA2556914A1 Amines and amides for the treatment of diseases
09/09/2005CA2556872A1 Modulation of inflammatory and metastatic processes
09/09/2005CA2556738A1 Tetracyclic lactam derivatives and uses thereof
09/09/2005CA2555245A1 Antisense oligonucleotide modulation of stat3 expression
09/08/2005US20050197353 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases, atherosclerosis, etc.
09/08/2005US20050197352 Imidazo-substituted compounds as p38 kinase inhibitors
09/08/2005US20050197349 Pyrrolo[2,3-D]pyrimidine compounds
09/08/2005US20050197331 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
09/08/2005US20050197329 drugs such as 4-(4-{[amino(2-thienyl)methylidene]amino}phenyl)-N-(4-phenoxyphenyl)butanamide, used as nitric oxide synthase inhibitors and selective or non-selective traps for reactive oxygen species
09/08/2005US20050197328 2-(4-amino-furazan-3-yl)-1-ethyl-N-[(2R)-2-morpholinylmethyl]-1H-imidazo[4,5-c]pyridine-7-carboxamide; Mitogen- and Stress-Activated Protein (MSK) and Rho (guanosine triphosphate) 1 or 2 kinase inhibitor; neurodegenerative diaeases; antiinflammatory, anticarcinogenic, antiviral and antibacterial agent
09/08/2005US20050197323 Full or partial glucocorticosteroid replacement therapy for obstructive pulmonary bronchial diseases
09/08/2005US20050196443 Pulsatile release compositions and methods for enhanced intestinal drug absorption
09/08/2005US20050196428 Dilute aqueous solution containing epidermal growth factor in gel
09/08/2005US20050196401 Energy-activated targeted cancer therapy
09/08/2005US20050196385 Lymphocytic cells; industrial production of functional cells, pharmaceutical quality, large amounts; blood, plasma, serum from cytapheresis, frozen stock; cultured with synthetic activators phosphohalohydrin, phosphoepoxide, bisphosphonate,cytokine, interlukin; treat infection, parasites, cancer
09/07/2005EP1571146A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
09/07/2005EP1571142A1 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
09/07/2005EP1571140A1 C-substituted cyclohexylmethylamine derivatives
09/07/2005EP1570860A1 Antagonist and agonist binding to strong binding site of chemokine receptor
09/07/2005EP1570840A2 Topical composition comprising n-acetylaldosamines or n-acetylamino acids
09/07/2005EP1570823A2 Substained analgesia achieved with buprenorphine
09/07/2005EP1569958A2 Methods and materials for treating inflammatory conditions using a polypeptide comprising a self-c5 amino acid segment and a non-self amino acid segment
09/07/2005EP1569937A2 C-6 modified indazolylpyrrolotriazines
09/07/2005EP1569933A1 Pyrrolidine and azetidine compounds as ccr5 antagonists
09/07/2005EP1569913A1 Compositions containing pyrimidine derivatives as inhibitors of cox-2
09/07/2005EP1569907A1 Nicotinamide-based kinase inhibitors
09/07/2005EP1569896A1 Tetrahydro-naphthalene derivatives
09/07/2005EP1569692A2 Betaine and salicylic acid compositions
09/07/2005EP1569672A1 Method for preparing a centella asiatica extract rich in madecassoside and in terminoloside
09/07/2005EP1569653A1 Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k
09/07/2005EP1569640A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor
09/07/2005EP1569632A1 Composition for the treatment of pain, especially for the treatment of articular pain
09/07/2005EP1569629A1 Topical antiinflammatory preparations of g(g)-terpinene
09/07/2005EP1501834B1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors
09/07/2005EP1495023B1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
09/07/2005EP1458717B1 Aroyl pyridinones
09/07/2005EP1438291B1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
09/07/2005EP1366039B1 Piperazinylcarbonylquinolines and -isoquinolines
09/07/2005EP1328519B1 Orally active salts with tyrosine kinase activity
09/07/2005EP1326853B1 Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors
09/07/2005EP1307438B1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field
09/07/2005EP1299430B1 Process for preparing benzoxazin-4-one polymer conjugates
09/07/2005EP1282621B1 Vitronectin receptor antagonists
09/07/2005EP1254133B9 Indol-3-yl derivatives and their use as integrin inhibitors
09/07/2005EP1178794B1 Use of succinic acid derivatives to obtain a medicine for treating inflammation
09/07/2005CN1665929A Circular dumbbell decoy oligodeoxynucleotides (CDODN) containing DNA bindings sites of transcription
09/07/2005CN1665831A Novel compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules
09/07/2005CN1665829A Nonsteroidal anti-inflammatory substances, compositions and methods for their use
09/07/2005CN1665822A 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/07/2005CN1665821A 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/07/2005CN1665818A N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
09/07/2005CN1665817A Process for preparing certain pyrrolotriazine compounds
09/07/2005CN1665810A Inhibitors of JAK and CDK2 protein kinases
09/07/2005CN1665809A Azaindoles
09/07/2005CN1665807A Novel physiolgically active substances
09/07/2005CN1665800A Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
09/07/2005CN1665780A Tricyclic steroid hormone nuclear receptor modulators
09/07/2005CN1665778A Hydroxy tetrahydro-naphthalenylurea derivatives
09/07/2005CN1665539A Pharmaceutical compositions containing anticholinergics and EGFR kinase inhibitors
09/07/2005CN1665538A Phamaceutical combination of a thromboxane A2 receptor antagonist and a COX-2 inhibitor
09/07/2005CN1665537A Use of CETP inhibitors and optionally HMG COA reductable inhibitors and/or antihypertensive agents
09/07/2005CN1665534A Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
09/07/2005CN1665526A Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
09/07/2005CN1665524A Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors
09/07/2005CN1665514A Drugs for treating or preventing disorders of corneal and/or conjunctival epithelial cells
09/07/2005CN1665513A 1, 3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/07/2005CN1665507A Therapeutic 1, 2, 3, 6-tetrahydropyrimidine-2-one compositions and methods therewith
09/07/2005CN1663599A Improved plaster for treating rheumatic and rheumatoid diseases and preparation method thereof
09/07/2005CN1663580A Pain-relieving plaster for rheumatism and its preparation
09/07/2005CN1663579A Pain-relieving bolus for rheumatism and its preparation
09/07/2005CN1663577A Chinese medicinal composition for treating rheumatic and rheumatoid arthritis
09/07/2005CN1663575A Chinese medicinal composition for treating rheumatic and rheumatoid arthritis
09/07/2005CN1663570A Pharmaceutical composition with anti-infection, fever-relieving, pain-stopping functions
09/07/2005CN1217943C New use and novel N-azabicyclo-amide derivatives
09/07/2005CN1217942C Pyrrolidine derivatives having phospholipase A inhibitory activity
09/07/2005CN1217936C Heterocyclic compounds having sulfonamide
09/07/2005CN1217926C Novel vitamin D analogues
09/07/2005CN1217922C 2-amino-2-alkyl-4-hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
09/07/2005CN1217918C Aminocyclohexyl ether compounds and uses thereof
09/07/2005CN1217686C Preparation method of dairy cattle mammitis antinflammation powder
1 ... 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 ... 1272